Abstract: The purpose of the present invention is to provide: a compound having an sEH inhibiting activity; and a medicinal agent capable of exhibiting a therapeutic or prophylactic effect on chronic kidney diseases and pulmonary hypertension which relies on a sEH inhibiting activity. The present invention provides a nipecotic acid derivative represented by chemical formula (1) or a pharmacologically acceptable salt thereof.
| # | Name | Date |
|---|---|---|
| 1 | 2144-KOLNP-2014-AbandonedLetter.pdf | 2019-01-04 |
| 1 | GPA.pdf | 2014-10-28 |
| 2 | 2144-KOLNP-2014-FER.pdf | 2018-05-16 |
| 2 | F5.pdf | 2014-10-28 |
| 3 | 2144-KOLNP-2014-(19-01-2015)-ANNEXURE TO FORM 3.pdf | 2015-01-19 |
| 3 | F3.pdf | 2014-10-28 |
| 4 | 2144-KOLNP-2014-(19-01-2015)-CORRESPONDENCE.pdf | 2015-01-19 |
| 4 | F2.pdf | 2014-10-28 |
| 5 | DRWNGS.pdf | 2014-10-28 |
| 5 | 2144-KOLNP-2014.pdf | 2014-11-01 |
| 6 | 2144-KOLNP-2014.pdf | 2014-11-01 |
| 6 | DRWNGS.pdf | 2014-10-28 |
| 7 | 2144-KOLNP-2014-(19-01-2015)-CORRESPONDENCE.pdf | 2015-01-19 |
| 7 | F2.pdf | 2014-10-28 |
| 8 | 2144-KOLNP-2014-(19-01-2015)-ANNEXURE TO FORM 3.pdf | 2015-01-19 |
| 8 | F3.pdf | 2014-10-28 |
| 9 | 2144-KOLNP-2014-FER.pdf | 2018-05-16 |
| 9 | F5.pdf | 2014-10-28 |
| 10 | GPA.pdf | 2014-10-28 |
| 10 | 2144-KOLNP-2014-AbandonedLetter.pdf | 2019-01-04 |
| 1 | SearchStrategy_16-05-2018.pdf |